These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22486520)

  • 1. Oral contraception in Denmark 1998-2010.
    Wilson NM; Laursen M; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2012 Jul; 91(7):810-5. PubMed ID: 22486520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal contraception and venous thromboembolism.
    Lidegaard Ø; Milsom I; Geirsson RT; Skjeldestad FE
    Acta Obstet Gynecol Scand; 2012 Jul; 91(7):769-78. PubMed ID: 22568831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
    Lidegaard Ø; Nielsen LH; Skovlund CW; Skjeldestad FE; Løkkegaard E
    BMJ; 2011 Oct; 343():d6423. PubMed ID: 22027398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of oral contraceptives in Denmark 1980-1990 and smoking habits among fertile women in 1990].
    Lidegaard O
    Ugeskr Laeger; 1993 Nov; 155(44):3550-8. PubMed ID: 8236576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
    van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
    Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
    Odlind V; Milsom I; Persson I; Victor A
    Acta Obstet Gynecol Scand; 2002 Jun; 81(6):482-90. PubMed ID: 12047300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
    Lindberg M; Foldemo A; Josefsson A; Wiréhn AB
    Eur J Contracept Reprod Health Care; 2012 Apr; 17(2):106-18. PubMed ID: 22385398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin, leptin and lipid profiles evaluation in oral contraceptive pill consumers.
    Fallah S; Sanjary Pour M; Rabbani Chadegani A; Korani M
    Arch Gynecol Obstet; 2012 Jun; 285(6):1747-52. PubMed ID: 22210292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
    Ishak R; Loh Chooi Khim
    Malays J Reprod Health; 1991 Jun; 9(1):5-8. PubMed ID: 12317443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
    Gaspard U; Lambotte R
    Bull Mem Acad R Med Belg; 1991; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraception.
    Huggins GR
    Curr Opin Obstet Gynecol; 1990 Apr; 2(2):291-5. PubMed ID: 2102326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral and intrauterine contraception. Use and adverse effects].
    Gram LF; Kovács I; Pedersen A
    Ugeskr Laeger; 1976 May; 138(19):1133-9. PubMed ID: 1265912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.